A Phase II, Multicentre, Randomised, Assessor-Blinded, Active-Comparator, Parallel-Group Dose Finding Trial to Evaluate AS900672-Enriched [recombinant follicle stimulating hormone] Versus Follitropin Alfa (GONAL-f) in Oligo-Anovulatory Infertile Women Undergoing Ovulation Induction (OI)

Trial Profile

A Phase II, Multicentre, Randomised, Assessor-Blinded, Active-Comparator, Parallel-Group Dose Finding Trial to Evaluate AS900672-Enriched [recombinant follicle stimulating hormone] Versus Follitropin Alfa (GONAL-f) in Oligo-Anovulatory Infertile Women Undergoing Ovulation Induction (OI)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2013

At a glance

  • Drugs Recombinant follicle-stimulating hormone (Primary) ; Follitropin alfa
  • Indications Infertility
  • Focus Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 17 Dec 2009 Actual patient number (71) added as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 Aug 2009 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top